Stem cell therapy approved for clinical trials
PALO ALTO, Calif. (KGO) -- A therapy developed by Palo Alto-based Stem Cells Inc. and researchers at U.C. Irvine has been approved for the world's first clinical trial using human neural stem cells to treat spinal cord injuries.
The treatment will target spinal injuries that are three to 12 months old.
Researchers will begin enrolling patients early next year.
stem cell research, palo alto, health
- 1 dead, 2 injured in Redwood City boating accident
- Mother, child killed in San Francisco fire
- San Francisco officials plan to crack down on "420"
- SF Chinese community faces fallout from Yee arrest
- Serious accident on Almaden Expressway in San Jose 42 min ago
- Possible explosive prompts evacuations in Solvang
- Firetruck rams California eatery; 15 injured
- BART unveils new train car design in SF
- Man accused of killing Sierra LaMar appears in court
- VIDEO: Man kicked in head taking selfie in...
- Angels beat A's 5-4 on Iannetta's HR in 12th
- Photos: The 10 worst jobs for 2014
- weather: Bay Area weather forecast for Thursday
- roundup: Hammer beating; SF "420" crackdown 20 min ago
- Bay Area weather forecast for Thursday
11 min ago